|Bid||128.02 x 100|
|Ask||0.00 x 0|
|Day's Range||173.23 - 174.63|
|52 Week Range||134.19 - 181.72|
|PE Ratio (TTM)||14.24|
|Earnings Date||Apr 23, 2018 - Apr 27, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||193.35|
A business unit of Laboratory Corporation of America Holdings has created a division to focus on offerings to help further the development of biologic drugs, the Burlington-based company said. The creation of the immunology and immunotoxicology unit by Covance Drug Development comes as LabCorp has focused on expanding its operations beyond laboratory diagnostics in order to become a global life sciences company. LabCorp (LH) acquired Covance for $6.2 billion in 2015.
LabCorp® announced today that for the period of March 12, 2018 to September 11, 2018, its Zero Coupon Convertible Subordinated Notes due 2021 will accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 9, 2018, in addition to the continued accrual of the original issue discount.
Almost a year after acquiring Pathology Associates Medical Laboratories, LabCorp will lay off about 195 employees with the Spokane, Washington-based company. The layoffs, which will take place in the next several months, will only occur in Spokane. Once complete, the company will have about 500 employees in the area, said Don Von Hagen, spokesperson for Laboratory Corporation of America Holdings (LH).
LabCorp® , a leading global life sciences company, announced today that its Covance Drug Development business has formed a global immunology and immunotoxicology unit dedicated to the specific needs of biologic drug development.
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting LH. Over the last one-month, outflows of investor capital in ETFs holding LH totaled $16.22 billion.
LabCorp® today announced it will participate at the 2018 Barclays Global Healthcare Conference. LabCorp’s presentation is planned for Wednesday, March 14, 2018 at 9:30 am .
As part of a community service campaign, an enthusiastic group of LabCorp employees teamed up with Cheeriodicals to assemble and deliver 128 big green boxes to children patients at Florida Hospital Memorial Medical Center and Halifax Health Medical Center during a “Cheeriodicals Day” event held last week.
Stock Monitor: BioTelemetry Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 1, 2018 / Active-Investors.com has just released a free earnings report on Laboratory Corp. of America Holdings (NYSE: ...
LabCorp® , a leading global life sciences company, announced today that its Covance Drug Development business has entered into a strategic technology agreement with GlaxoSmithKline plc .
Lincoln Financial Group, citing strong the company's strong earnings in 2017, will give certain employees a one-time grant of 20 shares of company stock. Lincoln Financial Group (LNC) said Wednesday the shares will be given to full-and part-time employees who do not already participate in the equity plan. Eligible employees will receive the grant in conjunction to the company's annual incentive plan, which includes a cash bonus tied to Lincoln Financial's financial performance.
Laboratory Corp of America Holdings (NYSE:LH) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Zacks.com highlights: Pfizer, Laboratory Corporation of America Holdings, Hill-Rom Holdings, HCA Healthcare and Terex
One of the fundamental metrics for finding GARP is PEG ratio. Although it is categorized under value investing, this strategy follows the principles of both growth and value investing.
LabCorp® , a leading global life sciences company, will host an Investor and Analyst Day for institutional investors and financial analysts in New York City on Tuesday, February 27, 2018.
King is one of many CEOs to gather at North Ridge Country Club for the N.C. CEO Forum’s 2018 Healthcare Summit. The discussion has centered on how technology will “disrupt” the health care sector by tackling the industry’s inefficiencies (here’s looking at you, Amazon).
This could indicate that investors who seek to profit from falling equity prices are not currently targeting LH. LH credit default swap spreads are within the middle of their range for the last three years.
Here we look at the major factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.
Centene and Laboratory Corp. of America were among the healthcare stocks in the green on Tuesday, Feb. 6, amid a volatile trading day in the stock market.
LabCorp's (LH) Covance Drug Development of late begins to gain traction from Chiltern acquisition, strong organic growth and a favorable foreign currency translation.
LabCorp (LH) witnessed year over year growth in net revenue on the back of both LabCorp Diagnostics and Covance Drug Development segment in Q4.